Note: Supplemental materials are not guaranteed with Rental or Used book purchases.
Purchase Benefits
What is included with this book?
Preface | p. xi |
About the Authors | p. xv |
Acknowledgments | p. xvii |
Epidemiology, Assessment, Causes, and Risks Associated with Presence of Overweight and Obesity | p. 1 |
Current Obesity Trends | p. 3 |
Obesity Prevalence in the United States | p. 4 |
Obesity Definition | p. 4 |
How Obesity Data Are Collected | p. 6 |
Trends in Obesity: Increasing or Levelling Off? | p. 6 |
Extreme Obesity | p. 7 |
Childhood Obesity | p. 7 |
Disparities According to Sex and Ethnicity | p. 8 |
Effects of Socioeconomic Status | p. 10 |
Global Trends | p. 10 |
Summary | p. 11 |
Assessment of Body Weight and Body Composition | p. 15 |
Anthropometric Assessment of Optimal Body Weight | p. 16 |
Height-Weight Tables | p. 16 |
Calculating Ideal Body Weight | p. 16 |
Comprehensive and Consistent Assessment of Overweight and Obesity Recommended by National Institutes of Health (NIH) | p. 17 |
How is BMI Useful? | p. 18 |
Calculating BMI | p. 18 |
BMI Categories | p. 19 |
BMI Variation According to Ethnicity | p. 19 |
BMI Limitations | p. 21 |
Assessment of Body Composition and Fat Distribution | p. 22 |
Air and Water Displacement Techniques | p. 22 |
Dual Energy X-ray Absorptiometry (DEXA) | p. 23 |
Bioelectrical Impedance Analysis (BIA) | p. 24 |
Skinfold Measurement | p. 25 |
What Is a Normal Body Fat Percentage? | p. 25 |
Is Waist Circumference Measurement Better at Assessing Risk Than BMI? | p. 25 |
Presence of Other Risk Factors or Disease Comorbidities | p. 27 |
Methods to Assess Childhood and Adolescent Overweight and Obesity | p. 29 |
Summary | p. 29 |
Causes of Obesity | p. 33 |
Factors That Contribute to Obesity | p. 34 |
Energy Balance | p. 34 |
Metabolic Rate | p. 35 |
Energy Expenditure Terminology, Measurement, and Equations | p. 37 |
Equations for Calculation of BMR | p. 38 |
Thermic Effect of Food | p. 38 |
Energy Used During Physical Activity | p. 39 |
Environmental Contributors to Increased Energy Intake | p. 39 |
Food Availability | p. 40 |
Beverages Add More Calories | p. 40 |
Increased Portion Sizes | p. 41 |
Eating Away from Home | p. 41 |
Impact of Socioeconomic Status | p. 42 |
Reduced Opportunity for Physical Activity | p. 42 |
Metabolic and Genetic Contributions to Eating Behavior | p. 42 |
Homeostatic Controls | p. 42 |
Hendonic Systems | p. 44 |
Genetic Contributions to Obesity | p. 44 |
Summary | p. 45 |
Health and Economic Consequences of Obesity | p. 51 |
Health and Economic Consequences of Obesity | p. 52 |
Characteristics of Obesity Comorbidities | p. 52 |
An Increase in Frequency and Severity of the Disease Occurs When Adiposity Is Present | p. 52 |
An Improvement or Resolution of the Disease Occurs with Weight Loss | p. 52 |
A Plausible Explanation Exists for the Association of Obesity with the Disease State | p. 52 |
Obesity and Metabolic Syndrome | p. 53 |
Nonalcoholic Fatty Liver Disease | p. 54 |
Polycystic Ovary Syndrome | p. 55 |
Type 2 Diabetes | p. 55 |
Cardiovascular Disease | p. 56 |
Respiratory Disease | p. 58 |
Obstructive Sleep Apnea | p. 58 |
Asthma | p. 58 |
Malignancies | p. 58 |
Musculoskeletal Disorders | p. 58 |
Longevity | p. 59 |
Controversies About Obesity and Longevity | p. 59 |
Psychosocial Correlates of Obesity | p. 59 |
Quality of Life | p. 59 |
Discrimination and Bias | p. 60 |
Psychological Implications | p. 61 |
Economic Costs of Obesity | p. 61 |
Summary | p. 62 |
Strategies and Research for Weight Management and Obesity Prevention | p. 67 |
Dietary Interventions for Obesity Prevention and Management | p. 69 |
Energy Requirements for Weight Management | p. 70 |
Dietary Recommendations for Weights Management | p. 71 |
Food Groups and Energy Density | p. 72 |
Fruits and Vegetables Food Group | p. 72 |
Grains Food Group | p. 72 |
Dairy Food Group | p. 73 |
Protein Food Group | p. 73 |
Solid Fats and Added Sugars | p. 73 |
Alcoholic Beverages | p. 75 |
Portion Control | p. 75 |
Food Labels | p. 77 |
Timing of Meals | p. 78 |
Specific Diet Plans | p. 78 |
Calorie-Reduced Diets | p. 78 |
Recommended Macronutrient Distribution | p. 78 |
Low-Fat, High-Carbohydrate, High-Fiber Diets | p. 79 |
High-Protein, Low-Carbohydrate Diets | p. 79 |
Medically Supervised Very-Low-Calorie Diets | p. 79 |
Research Comparison of Diets | p. 80 |
Popular Diet Plans | p. 80 |
How Do We Know What Works? | p. 82 |
Summary | p. 83 |
Physical Activity | p. 87 |
Energy Balance and Physical Activity | p. 88 |
Definitions of Physical Activity | p. 88 |
Trends in Physical Activity | p. 89 |
How Physical Activity Data Are Collected | p. 90 |
Recommendations for Physical Activity | p. 93 |
Physical Activity for Good Health, Fitness, and Prevention of Obesity | p. 93 |
Physical Activity Recommendations for Children and Youth | p. 94 |
Physical Activity for Weight Loss | p. 94 |
Physical Activity to Prevent Weight Regain | p. 95 |
Physical Activity and the National Weight Control Registry Participants | p. 96 |
Benefits, Risks, and Costs of Physical Activity | p. 97 |
Metabolic Health | p. 97 |
Risks | p. 98 |
Costs | p. 99 |
Summary | p. 99 |
Pharmacologic Agents in Obesity Management | p. 103 |
Medications for Weight Loss | p. 104 |
Incidence: How Many People Use Weight-Loss Medications? | p. 104 |
How Are Prescription Weight-Loss Medications Regulated? | p. 105 |
Pharmacological Mechanisms of Prescription Weight-Loss Medications | p. 105 |
Products That Work Systematically as Appetite Suppressants | p. 105 |
Products That Inhibit Absorption of Fat from the Gastrointestinal Tract | p. 107 |
Availability of Prescription Medications for Weight Loss/Management | p. 107 |
Appetite Suppressants | p. 107 |
Lipase Inhibitors | p. 109 |
Other Types of Medications Used for Obesity Treatment | p. 110 |
Potential Benefits of Weight-Loss Medications | p. 110 |
Potential Risks Associated with Weight-Loss Medications | p. 110 |
Treatment Guidelines | p. 111 |
Will Insurance Cover the Cost of Weight-Loss Medications? | p. 112 |
Over-the-Counter (OTC) Medications for Weight Loss/Management | p. 112 |
Dietary Supplement Therapies for Weight Loss | p. 114 |
Supplements Regulation and FDA Oversight | p. 114 |
How is Advertising of Weight-Loss Products Regulated? | p. 115 |
Red Flag Campaign | p. 115 |
Summary | p. 115 |
Surgical Options for Obesity | p. 119 |
Surgery for Severe Obesity | p. 120 |
History | p. 120 |
Incidence | p. 120 |
Indications | p. 120 |
Age Limits | p. 121 |
Contraindications | p. 121 |
Before Surgery | p. 121 |
Weight Loss Before Surgery | p. 122 |
Categories of Procedures | p. 123 |
Malabsorptive Versus Restyrictive | p. 123 |
Open Versus Laparoscopic | p. 123 |
Gastric Bypass Surgery | p. 124 |
Complications and Risks of Gastric Bypass Surgery | p. 124 |
Centers of Excellence | p. 126 |
Benefits/Outcomes of Gastric Bypass Surgery | p. 126 |
Laparoscopic Adjustable Gastric Banding | p. 127 |
Outcomes Associated with Gastric Banding | p. 127 |
Long-Term Success | p. 127 |
Insurance Coverage and Accessibility | p. 129 |
Future Techniques | p. 129 |
Summary | p. 131 |
Behavioral Aspects of Weight Management | p. 135 |
Behavior Therapy Assumptions and Characteristics | p. 136 |
Assess Readiness to Lose Weight | p. 136 |
Set Goals | p. 136 |
SMART Goals for Weight Management | p. 137 |
Realistic Expectations | p. 137 |
Apply Behavior Modification Techniques | p. 139 |
Self-Monitoring | p. 139 |
Stimulus Control | p. 141 |
Cognitive Behavior Therapy | p. 142 |
Social Support Network | p. 143 |
Treatment Delivery Options | p. 143 |
Individual Versus Group Therapy | p. 143 |
Internet-Based Programs | p. 144 |
Long-Term Weight Maintenance | p. 144 |
Health at Every Size | p. 145 |
Summary | p. 146 |
Where Does Responsibility Lie? | p. 151 |
Where Does Responsibility Lie? | p. 152 |
Individuals | p. 152 |
Families | p. 152 |
Environment: Food and Physical Activity Accessibility | p. 153 |
Schools | p. 153 |
Worksites | p. 154 |
Advertising | p. 154 |
Stakeholder Responses to Obesity Issues | p. 155 |
Healthcare Providers | p. 155 |
Schools | p. 156 |
Worksites | p. 157 |
Public Health | p. 159 |
State and Community Government and Organizations | p. 159 |
National Programs | p. 162 |
Industry | p. 164 |
Summary | p. 165 |
New Insights and Future Directions in Obesity Research | p. 171 |
New Insights for Future Obesity Research | p. 172 |
Links Between Intenstinal Bacteria and Obesity | p. 172 |
Introduction to Microbiota | p. 172 |
Variations in Microbiota | p. 173 |
Mechanisms of Action Related to Obesity | p. 175 |
New Discoveries Based on Microbial DNA Sequencing | p. 175 |
Viruses Potentially Causes Obesity | p. 177 |
Viruses and Obesity in Animals | p. 177 |
Adenovirus-36 | p. 177 |
Viruses and Obesity in Humans | p. 177 |
Areas for Future Research | p. 178 |
Environmental Obesogens | p. 179 |
Obesogen Exposure | p. 179 |
Endocrine Disrupting Chemicals Mechanisms of Action | p. 180 |
Embryonic and Perinatal Exposures | p. 181 |
Sleep Disturbances and Energy Balance | p. 183 |
Changes in Sleep over Time | p. 183 |
Variations in Measurement of Sleep Duration | p. 184 |
Causes of Short Sleep | p. 184 |
Studies Relating Sleep Duration to Obesity | p. 184 |
Obesity Spreads Within Social Networks | p. 186 |
Framingham Heart Study Social Network | p. 186 |
Study Results | p. 186 |
Reasons for Social Influence on Obesity | p. 187 |
Glossary | p. 191 |
Index | p. 195 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.